Stay updated on NICHE: Clinical Trial on IO in Early Colon Cancer
Sign up to get notified when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.

Latest updates to the NICHE: Clinical Trial on IO in Early Colon Cancer page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%
- Check23 days agoChange DetectedUpdate to revision to v3.1.0 with new contact details; removal of the previous 'Last Update Posted' line indicates a change in how updates are presented.SummaryDifference0.1%
- Check30 days agoChange DetectedExpanded and updated trial details: new cohorts 7 and 8 with randomized design and neoadjuvant nivolumab +/- relatlimab, updated treatment windows, dosing, and recruitment status, plus trial identifiers. Minor reductions include earlier shorter duration and removed dosing specifics for some cohorts from the deletion set.SummaryDifference13%
- Check37 days agoChange DetectedRevision: v3.0.2 added; v3.0.1 removed; 'Back to Top' link removed.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has been updated to include a new facility name and location in The Hague, Netherlands, along with several new references to recent medical studies related to neoadjuvant immunotherapy for colon cancer. Additionally, some outdated terms and references have been removed.SummaryDifference13%
Stay in the know with updates to NICHE: Clinical Trial on IO in Early Colon Cancer
Enter your email address, and we'll notify you when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.